News

Weight-loss drugs significantly improve health, though they’re also tied to increased spending on other medical care that’s ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
The list price for a month’s supply of 2.4mg Wegovy – the drug’s highest dose – is $1,350 in the US, whereas the same dose in the UK costs £175.80 each month.
That was a steep discount to Wegovy’s list price of $1,350 per month, and consumers leapt at the opportunity to get a cheaper version of a GLP-1 weight loss drug.
Fifty-one percent of employers with 500+ workers will increase cost-sharing by 2026. Weight-loss drug costs, like Novo Nordisk's Wegovy, are a major concern for employers.